Athena Diagnostics on Monday asked the full Federal Circuit to reconsider a February ruling by a split, three-judge panel that said its patent on an autoimmune disease diagnostic test is invalid under Supreme Court precedent because it claims only a natural law…

Read this piece in its entirety at Law360.